Approval · Notice of Compliance 23218 · 2020
ROCURONIUM BROMIDE INJECTION: Notice of Compliance 23218
Issued February 17, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23218
- Date
- February 17, 2020
- Company
- Mda Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Update the product monograph
- Canadian reference product
- ZEMURON (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROCURONIUM BROMIDE INJECTION | Not yet assigned | — |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML